Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How does delaying the filing accommodate a deal? I don't see how that helps them in any negotiations, etc.. Maybe they want to announce a deal at the same time, but that's a bad reason to hold up the filing, IMHO.
That's not usually the case, if the acquirer believes the acquired company is on the right track they would usually let them continue to hire where necessary during any negotiations, or even after a deal is announced.
They made 20% in the last two weeks, I would take it.
I don't think there is any guarantee we will know more in a month or so, we have found out practically nothing in the last 7 months.
I don't believe DOC left of his own accord, which would add even more credence to the need for the retention bonuses for the people left behind. Even without a big separation payment, those people may have been (and may still be) inclined to follow him.
I think the reason for the retention bonuses was simply because the board was afraid those people would leave, and then they would have a big problem. They may also have been afraid those people would follow DOC, which makes be a bit nervous about the 3/1/18 date. Not uncommon to have retention bonuses simply because there is a flight risk that is critical to the company, and merger retention bonuses usually happen after the merger for the same reason, so that the buying company holds on to what they paid for in the deal.
I hope you're right, but I'm afraid this is all wishful thinking - a buyout has been discussed here ever since last summer (or earlier) when exel_mm kept talking about $4.2B popping into his head all the time.
But to get EMA approval they have to file the request, I'm no longer taking that for granted. Certainly not taking it for granted that it will happen in Q1, however maybe it will work out just like the AT-014 approval, right at the end of the quarter. Would be nice if it happened a lot earlier.
Down 20% in two weeks, what a nightmare.
Thanks, I didn't think I heard it, but didn't have a chance to check the conference call again.
Agreed, this is like water torture until they address the funding problem, one way or other. Some ways may be more painful than others.
Pretty much on a straight line down since a little jump at the open.
I'll say.
When did ADXS state the Amgen deal is being amended?
Although we've seen bigger down moves by ADXS, today it was down more than the market, once again. This pain is not going to end until they show a clear path to viability, which means they need money, have to file with the EMA, find a partner, etc..
I'm afraid we are in for many more months, I'm certainly not counting on anything this month.
It's certainly taking a lot of blind faith.
Let's hope so, but I wouldn't hold my breath waiting for the big announcement.
I don't disagree with any of that, except that I believe the money problem is overriding everything right now. Until that gets solved, and there is a pretty long runway that overlaps with very probable, significant revenue, I think we are stuck in the doldrums. Also, anything that you listed as pending is not likely to be considered positive, given the recent track record.
No arguments here.
I just don't buy the conspiracy theory, there are plenty of legitimate reasons why this has gone down, and is now stuck at low levels. Even Iggy admitted that the delays are bad news. I keep hoping for some good developments, but they sure are hard to come by here.
This is just brutal, every move up evaporates.
I was hoping we could avoid the end of day tank, but here it is.
The only good news here is that everyone else may have already seen this coming, and that's why we're at ~$3 right now. If dilution is believed to be inevitable, it may already be somewhat priced into the stock. Although based on today's reaction, not completely.
I think you could argue Tony has been misleading at best. He clearly said something about hoping to be able to announce something about an agreement for the EU back at the conference in November, now nothing for almost 3 months. On the earnings conference call he also said something to the effect that they were ready to file the EMA application, now nothing for more than a month. We thought he was giving out conservative dates for everything, now I am not so sure.
I just don't believe the manipulation argument any more, there has been plenty of bad news and no news over the last year+ that fully explain what has happened to this stock. The Amgen deal was just a blip on the radar, and that's why it continued down shortly after that. I'm a believer in the science, but management has us heading for dilution or worse in the next 6 months, which is now consistent with the need to authorize more shares.
That's just being ignorant of the obvious and reality.
Read between the lines, this means they know they are going to need those shares to sell, given the current stock price, to get anywhere near enough money to continue to fund operations through EU approval. This didn't simply happen because they are planning for the really long term future, this is because they will need to sell 30M shares at current prices to get funds they need - in a few months.
Authorizing more shares is a pretty clear indication that they do not have any deal lined up for other money. Why do it if there was something big right around the corner? However, it could mean they have someone lined up to buy those shares, which might be the best dilution possible.
Not so much today. Volume has also dried up.
What do you mean, keep what? These were put options, so if they were exercised then the holder probably owned the shares and exercising the options means the shares were sold. Or maybe the holder went short by exercising.
The problem is they can't just wait, they need more funds. Would be a whole different story if they had 3 years worth of money in the bank, but as it stands they need more cash sooner rather than later. That's why I don't think any of the things you mention will help in the short term, maybe in the the long term.
And I don't think the combo results with Keytruda are that critical. More important to get revenue, and the only way for that to happen is to get approval for AXAL. In the end, NEO will probably be much more important than anything else.
There is something a little bit different going on today, low/no volume at the start, then some relatively heavy volume and a quick move down, finally some moderate volume and a move back up.
There will be plenty of runs at it after this.
Practically 0 volume at the open today, interesting.
Maybe ADXS needs their own manufacturing to support NEO, so they need to contract out for AXAL/DUAL, etc..
But the book value of this company goes down by about $300K every business day, so I think you could argue the stock price has been following that. Until something happens that makes that trend change, now or with some likelihood in the future, I think we are stuck in a rut.
FWIW, it looks like the press releases page on the Advaxis web site has been updated.
Fair enough, I just hope they can get the EMA filing done long before the end of Q1. From what was said in the conference call, it sounded like it really should not take anywhere near that long.